Search Results 701-710 of 15886 for Isotope

  1. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

    This two-part, part 1: open-label extension (OLE) and part 2: safety monitoring (SM) study will examine the efficacy and safety of continued etrolizumab ...

  2. A Study Of IDRX-42 Versus Sunitinib In Participants With Metastatic And/or Unresectable Gastrointestinal Stromal Tumors (GIST) After Imatinib Therapy (StrateGIST 3) - Mayo Clinic

    The purpose of this study is to compare the efficacy of IDRX-42 to that of sunitinib in participants with metastatic and/or unresectable GIST after failure of ...

  3. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

    About this study. The purposes of this study are to prevent COVID-19 (CoV) disease complications by a 7 point score adapted from the World Health ...

  4. Publications - Mark J. Hoegger - Mayo Clinic

    Friedman DD, Ponkowski MJ, Shetty AS, Hoegger MJ, Itani M, Rajput MZ, Mellnick VM, Raptis CA, Northrup BE, Ballard D, Cabrera Lebron JA, Tsai R. CT Angiography ...

  5. Lipid Homeostasis and Neurobiology in Aging and Dementias: Takahisa Kanekiyo - Mayo Clinic Research

    Pictured are human induced pluripotent stem cells differentiated into endothelial cells. These cells are expressing tight junction protein ZO-1, shown in ...

  6. Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis - Mayo Clinic

    The primary hypothesis of the study is that treatment with pacritinib results in a greater proportion of patients achieving ≥ 35% reduction in spleen volume ...

  7. A Study to Collect Clinical Outcomes of Anatomic and Reverse Total Shoulder Arthroplasty

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Arteriosclerosis / atherosclerosis - Doctors and departments - Mayo Clinic

    Mayo Clinic healthcare professionals perform research to develop new treatments for atherosclerosis. They also study ways to reduce the risk of heart attacks ...

  9. Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) - Mayo Clinic

    Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), ...

  10. Biospecimens analysis in healthy controls - Mayo Clinic

    The purpose of this study is to collect healthy patient samples and give us a normal patient levels of antibodies, cytokines and other meaningful biomarkers ...